Studies on plasmepsins I and II from the malarial parasite Plasmodium falciparum and their exploitation as drug targets

Adv Exp Med Biol. 1998:436:397-406. doi: 10.1007/978-1-4615-5373-1_56.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antimalarials / pharmacology*
  • Aspartic Acid Endopeptidases / antagonists & inhibitors
  • Aspartic Acid Endopeptidases / genetics
  • Aspartic Acid Endopeptidases / metabolism*
  • Enzyme Inhibitors / pharmacology*
  • Hemoglobins / metabolism
  • Humans
  • Plasmodium falciparum / drug effects
  • Plasmodium falciparum / enzymology*
  • Plasmodium falciparum / growth & development
  • Protozoan Proteins

Substances

  • Antimalarials
  • Enzyme Inhibitors
  • Hemoglobins
  • Protozoan Proteins
  • Aspartic Acid Endopeptidases
  • plasmepsin
  • plasmepsin II